Market Place
Sourcing Support
Pathos AI Appoints Iker Huerga as CEO for AI Drug Development
08 May 2025 //
GLOBENEWSWIRE
Pathos AI gets AZ funding as biotech plans to raise up to $400M
03 May 2025 //
ENDPTS
Tempus AI in line for $200M from AstraZeneca cancer model deal
23 Apr 2025 //
FIERCE BIOTECH
Pathos AI Closes $62M Series C to Accelerate Drug Development
29 Oct 2024 //
GLOBENEWSWIRE
Pathos Secures Worldwide License For Phase 2-ready PRMT5 Inhibitor
15 Aug 2024 //
GLOBENEWSWIRE
Pathos Launches Oncology Pipeline With License of First Phase I Program
23 May 2023 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.